Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infraclavicular Block vs Local Infiltration for Wrist Arthroscopy
NCT02970097Withdrawn
- Sponsor
- University of Pennsylvania
- Start
- Sep 2016
- Primary completion
- Oct 2018
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, open-label trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms), sponsored by University of Pennsylvania. Primary endpoints: Visual Analog Scale Pain Score at 72 hours and Opioid Consumption at 72 hours. Planned start Sep 2016; status: withdrawn.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02970097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02970097.